TY - JOUR AU - Fulgoni, V. L. AU - Keast, D. R. AU - Lieberman, H. R. PY - 2015 DA - 2015// TI - Trends in intake and sources of caffeine in the diets of US adults: 2001-2010 JO - Am J Clin Nutr VL - 101 UR - https://doi.org/10.3945/ajcn.113.080077 DO - 10.3945/ajcn.113.080077 ID - Fulgoni2015 ER - TY - JOUR AU - Hering-Hanit, R. AU - Gadoth, N. PY - 2003 DA - 2003// TI - Caffeine-induced headache in children and adolescents JO - Cephalalgia Int J Headache VL - 23 UR - https://doi.org/10.1046/j.1468-2982.2003.00576.x DO - 10.1046/j.1468-2982.2003.00576.x ID - Hering-Hanit2003 ER - TY - JOUR AU - Scher, A. I. AU - Stewart, W. F. AU - Lipton, R. B. PY - 2004 DA - 2004// TI - Caffeine as a risk factor for chronic daily headache: a population-based study JO - Neurology VL - 63 UR - https://doi.org/10.1212/01.WNL.0000145760.37852.ED DO - 10.1212/01.WNL.0000145760.37852.ED ID - Scher2004 ER - TY - JOUR AU - Hagen, K. AU - Thoresen, K. AU - Stovner, L. J. AU - Zwart, J. A. PY - 2009 DA - 2009// TI - High dietary caffeine consumption is associated with a modest increase in headache prevalence: results from the Head-HUNT Study JO - J Headache Pain VL - 10 UR - https://doi.org/10.1007/s10194-009-0114-6 DO - 10.1007/s10194-009-0114-6 ID - Hagen2009 ER - TY - JOUR AU - Derry, C. J. AU - Derry, S. AU - Moore, R. A. PY - 2014 DA - 2014// TI - Caffeine as an analgesic adjuvant for acute pain in adults JO - Cochrane Database Syst Rev VL - 12 ID - Derry2014 ER - TY - JOUR AU - Ward, N. AU - Whitney, C. AU - Avery, D. AU - Dunner, D. PY - 1991 DA - 1991// TI - The analgesic effects of caffeine in headache JO - Pain VL - 44 UR - https://doi.org/10.1016/0304-3959(91)90129-L DO - 10.1016/0304-3959(91)90129-L ID - Ward1991 ER - TY - JOUR AU - Sawynok, J. PY - 2011 DA - 2011// TI - Caffeine and pain JO - Pain VL - 152 UR - https://doi.org/10.1016/j.pain.2010.10.011 DO - 10.1016/j.pain.2010.10.011 ID - Sawynok2011 ER - TY - JOUR AU - Fredholm, B. B. AU - Battig, K. AU - Holmen, J. AU - Nehlig, A. AU - Zvartau, E. E. PY - 1999 DA - 1999// TI - Actions of caffeine in the brain with special reference to factors that contribute to its widespread use JO - Pharmacol Rev VL - 51 ID - Fredholm1999 ER - TY - JOUR AU - Sigmon, S. C. AU - Herning, R. I. AU - Better, W. AU - Cadet, J. L. AU - Griffiths, R. R. PY - 2009 DA - 2009// TI - Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects JO - Psychopharmacology VL - 204 UR - https://doi.org/10.1007/s00213-009-1489-4 DO - 10.1007/s00213-009-1489-4 ID - Sigmon2009 ER - TY - JOUR PY - 2013 DA - 2013// TI - The International Classification of Headache Disorders, 3rd edition (beta version) JO - Cephalalgia Int J Headache VL - 33 UR - https://doi.org/10.1177/0333102413485658 DO - 10.1177/0333102413485658 ID - ref10 ER - TY - JOUR AU - Barone, J. J. AU - Roberts, H. R. PY - 1996 DA - 1996// TI - Caffeine consumption JO - Food Chem Toxicol Int J Published British Ind Biol Res Assoc VL - 34 UR - https://doi.org/10.1016/0278-6915(95)00093-3 DO - 10.1016/0278-6915(95)00093-3 ID - Barone1996 ER - TY - JOUR AU - Chu, M. K. AU - Im, H. J. AU - Ju, Y. S. AU - Yu, K. H. AU - Ma, H. I. AU - Kim, Y. J. AU - Kim, J. AU - Lee, B. C. PY - 2009 DA - 2009// TI - Validity and reliability assessment of Korean headache impact test-6 (HIT-6) JO - J Korean Neurol Assoc VL - 27 ID - Chu2009 ER - TY - JOUR AU - Lipton, R. B. AU - Bigal, M. E. AU - Ashina, S. AU - Burstein, R. AU - Silberstein, S. AU - Reed, M. L. AU - Serrano, D. AU - Stewart, W. F. PY - 2008 DA - 2008// TI - Cutaneous allodynia in the migraine population JO - Ann Neurol VL - 63 UR - https://doi.org/10.1002/ana.21211 DO - 10.1002/ana.21211 ID - Lipton2008 ER - TY - JOUR AU - Goadsby, P. J. AU - Sprenger, T. PY - 2010 DA - 2010// TI - Current practice and future directions in the prevention and acute management of migraine JO - Lancet Neurol VL - 9 UR - https://doi.org/10.1016/S1474-4422(10)70005-3 DO - 10.1016/S1474-4422(10)70005-3 ID - Goadsby2010 ER - TY - JOUR AU - Gladstone, J. P. AU - Dodick, D. W. PY - 2004 DA - 2004// TI - Acute Migraine: Which Triptan? JO - Pract Neurol VL - 4 UR - https://doi.org/10.1111/j.1474-7766.2004.03-205.x DO - 10.1111/j.1474-7766.2004.03-205.x ID - Gladstone2004 ER - TY - JOUR AU - Dowson, A. J. AU - Tepper, S. J. AU - Baos, V. AU - Baudet, F. AU - D’Amico, D. AU - Kilminster, S. PY - 2004 DA - 2004// TI - Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire JO - Curr Med Res Opin VL - 20 UR - https://doi.org/10.1185/030079904125004079 DO - 10.1185/030079904125004079 ID - Dowson2004 ER - TY - JOUR AU - Johansson, B. AU - Georgiev, V. AU - Lindstrom, K. AU - Fredholm, B. B. PY - 1997 DA - 1997// TI - A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment JO - Brain Res VL - 762 UR - https://doi.org/10.1016/S0006-8993(97)00378-8 DO - 10.1016/S0006-8993(97)00378-8 ID - Johansson1997 ER - TY - JOUR AU - Shapiro, R. E. PY - 2007 DA - 2007// TI - Caffeine and headaches JO - Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol VL - 28 ID - Shapiro2007 ER - TY - JOUR AU - Silverman, K. AU - Evans, S. M. AU - Strain, E. C. AU - Griffiths, R. R. PY - 1992 DA - 1992// TI - Withdrawal syndrome after the double-blind cessation of caffeine consumption JO - N Engl J Med VL - 327 UR - https://doi.org/10.1056/NEJM199210153271601 DO - 10.1056/NEJM199210153271601 ID - Silverman1992 ER - TY - JOUR AU - Chiang, C. C. AU - Schwedt, T. J. AU - Wang, S. J. AU - Dodick, D. W. PY - 2016 DA - 2016// TI - Treatment of medication-overuse headache: A systematic review JO - Cephalalgia Int J Headache VL - 36 UR - https://doi.org/10.1177/0333102415593088 DO - 10.1177/0333102415593088 ID - Chiang2016 ER - TY - JOUR AU - Bendtsen, L. AU - Munksgaard, S. AU - Tassorelli, C. AU - Nappi, G. AU - Katsarava, Z. AU - Lainez, M. AU - Leston, J. AU - Fadic, R. AU - Spadafora, S. AU - Stoppini, A. AU - Jensen, R. AU - Consortium, C. PY - 2014 DA - 2014// TI - Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project) JO - Cephalalgia Int J Headache VL - 34 UR - https://doi.org/10.1177/0333102413515338 DO - 10.1177/0333102413515338 ID - Bendtsen2014 ER -